Concepedia

Author

Sarath Kanekal

Sapporo Medical University

Also Known As

S Kanekal, S. Kanekal, Sarath Kanekal

90

Publications

389

Citations

10

H-Index

19

Concepts

All Affiliations

Sapporo Medical UniversitySuperGen (United States)
SK

About

Sarath Kanekal is an author at Sapporo Medical University specializing in oncology, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

191

2

Cell Biology

3

3

173

3

Pharmacology

3

3

181

4

Immunology

1

1

18

5

Cancer Cell Biology

1

1

11

Sarath Kanekal

×

10

Publications

352

Citations

10

H-Index

YearCitations

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge,

Molecular Cancer Therapeutics

2009

152

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma

Hiroshi Yasui, Teru Hideshima, Makoto Hamasaki,

Blood

2005

60

Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma

Tony Mok, Sarath Kanekal, Xiao Lin,

Cancer

2001

30

S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)

Donald Lavelle, Yogen Saunthararajah, Kestis Vaitkus,

Journal of Translational Medicine

2010

30

<i>In vivo</i> and <i>in vitro</i> cytotoxicity of <i>R</i>‐etodolac with dexamethasone in glucocorticoid‐resistant multiple myeloma cells

Paola Neri, Hiroshi Yasui, Teru Hideshima,

British Journal of Haematology

2006

18

Circadian pharmacology of<scp>l</scp>-alanosine (SDX-102) in mice

Xiaomei Li, Sarath Kanekal, Delphine Crépin,

Molecular Cancer Therapeutics

2006

17

SDX-105 (Treanda™) Enhances the Tumor Growth Inhibitory Effect of Rituximab in Daudi Lymphoma Xenografts.

Sarath Kanekal, Brian Crain, Gary Elliott

Blood

2004

12

Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report

Dennis Brown, Zhongping Chen, C. Guo,

Glioma

2019

12

SDX-105 (Bendamustine) inhibits growth of SU-DHL-1 and Daudi lymphoma xenografts in SCID mice

Sarath Kanekal, Brian Crain, Gary Elliott,

Cancer Research

2004

11

Retention of intratumor injections of cisplatinum in murine tumors and the impact on laser thermal therapy for cancer treatment

Sarath Kanekal, Jayne Joo, Michael Bublik,

European Archives of Oto-Rhino-Laryngology

2008

10

Page 1